[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 23,978
  • Shares Outstanding, K 4,499
  • Annual Sales, $ 26,612 K
  • Annual Income, $ -1,124 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.93
  • Price/Sales 0.72
  • Price/Cash Flow 35.43
  • Price/Book 3.15

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.3300 +10.13%
on 05/07/26
6.6600 -11.86%
on 04/09/26
-0.7900 (-11.86%)
since 04/08/26
3-Month
5.3300 +10.13%
on 05/07/26
8.3400 -29.62%
on 02/20/26
-0.4500 (-7.12%)
since 02/06/26
52-Week
5.3300 +10.13%
on 05/07/26
21.0000 -72.05%
on 10/06/25
-5.5050 (-48.40%)
since 05/08/25

Most Recent Stories

More News
FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

HERZLIYA, Israel and CALGARY, AB , Feb. 27, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 5.8700 (+10.13%)
INNO : 17.72 (+0.57%)
INNPD : 12.5300 (-3.02%)
FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

HERZLIYA, Israel and CALGARY, AB , Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and...

INNO.CN : 5.8700 (+10.13%)
INNO : 17.72 (+0.57%)
INNPD : 12.5300 (-3.02%)
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)
Innocan Pharma Announces Details of Proposed Share Consolidation

/CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)
Innocan Pharma Announces First Half Of 2025 Financial Results

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering

/CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has publicly filed a...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)
Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 5.8700 (+10.13%)
INNPF : 4.4000 (-7.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

InnoCan Pharma Corp develops consumer wellness and pharmaceutical products. It has developed a preclinical-stage Cannabidiol-loaded Liposome injection Platform (CBD-LPT) for non-opioid pain management, and is involved in developing and marketing various self-care and CBD beauty products. Additionally,...

See More

Key Turning Points

3rd Resistance Point 5.8700
2nd Resistance Point 5.8700
1st Resistance Point 5.8700
Last Price 5.8700
1st Support Level 5.8700
2nd Support Level 5.8700
3rd Support Level 5.8700

See More

52-Week High 21.0000
Fibonacci 61.8% 15.0141
Fibonacci 50% 13.1650
Fibonacci 38.2% 11.3159
Last Price 5.8700
52-Week Low 5.3300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.